Synthekine
Latest round
- Series C
Last raised
- Dec 2022
Total raised
- $340M
Investors
- 11
About Synthekine
Synthekine Inc.Founded in 2018 and headquartered in Menlo Park, US, Synthekine Inc. specializes in engineered cytokine therapeutics.Synthekine develops engineered cytokine therapeutics, including cytokine partial agonists and surrogate cytokine agonists. These products aim to target significant medical needs in oncology and autoimmune diseases, focusing on enhancing efficacy and safety.Synthekine's revenue model relies on strategic partnerships with pharmaceutical companies, generating income from joint research agreements, milestone payments, and royalties linked to successful therapeutic developments.00 mn, Synthekine plans to advance its differentiated therapeutic pipeline and support new clinical studies, particularly for its IL-12 partial agonist program. The company is focused on launching new products and expanding into markets in North America, Europe, and Asia within the next few years.
Who invested in Synthekine
11 investors across 3 rounds
See all investors in Synthekine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synthekine
Who invested in Synthekine?
Synthekine has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synthekine raised?
Synthekine has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Synthekine last raise money?
Synthekine's most recent round on record is a Series C, in Dec 2022.
What does Synthekine do?
Synthekine is a biotechnology company.
Where is Synthekine headquartered?
Synthekine is headquartered in Menlo Park, US.
Which VCs invest in companies like Synthekine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Synthekine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Synthekine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.